Regression of upper gastric cancer in mice by FHIT gene delivery

Hideshi Ishii1, Nicola Zanesi, Andrea Vecchione

  • 1Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.

Insights

FHIT gene therapy using viral vectors significantly reduces carcinogen-induced forestomach tumors in mice. Oral delivery of FHIT expression viruses reverses established tumors by inducing apoptosis, highlighting its therapeutic potential.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • Reduced Fhit expression is common in various cancers.
  • FHIT gene replacement via viral vectors induces apoptosis in cancer cells.
  • Mice with inactivated Fhit alleles exhibit hypersensitivity to carcinogen-induced tumors.

Purpose of the Study:

  • Investigate the kinetics and mechanism of tumor reversal and intervention using oral FHIT gene delivery.
  • Evaluate the efficacy of FHIT viral gene therapy in a mouse model of forestomach tumors.

Main Methods:

  • Oral administration of FHIT expression viruses to mice with N-nitrosomethylbenzylamine (NMBA)-induced forestomach tumors.
  • Tumor burden analysis at different time points post-carcinogen exposure.
  • Assessment of Fhit expression, apoptosis markers (Bcl2, Bax, TUNEL), and viral infection effects.

Main Results:

  • FHIT virus treatment significantly reduced tumor burden compared to controls.
  • FHIT expression persisted for at least 82 days post-infection.
  • FHIT gene delivery led to reduced Bcl2, increased Bax expression, and increased apoptotic nuclei.
  • Control viral infection did not impact tumor development.

Conclusions:

  • FHIT viral gene delivery effectively prevents and reverses carcinogen-induced forestomach tumors.
  • The mechanism involves inducing apoptosis in tumor cells via the FHIT pathway.
  • Targeting the FHIT apoptotic pathway shows significant potential for tumor eradication.